These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22014121)

  • 1. Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients.
    Tatsukawa M; Takaki A; Shiraha H; Koike K; Iwasaki Y; Kobashi H; Fujioka S; Sakaguchi K; Yamamoto K
    BMC Cancer; 2011 Oct; 11():458. PubMed ID: 22014121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
    Park YM; Jang JW; Yoo SH; Kim SH; Oh IM; Park SJ; Jang YS; Lee SJ
    J Viral Hepat; 2014 Mar; 21(3):171-7. PubMed ID: 24344773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
    Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
    J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.
    Lee D; Lyu H; Chung YH; Kim JA; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ; Ryu SH
    World J Gastroenterol; 2016 Jun; 22(23):5393-9. PubMed ID: 27340355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.
    Jang JW; Chun JY; Park YM; Shin SK; Yoo W; Kim SO; Hong SP
    Cancer Sci; 2012 Feb; 103(2):296-304. PubMed ID: 22136288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of A1896, T1653 and T1762/A1764 mutations in genotype c2 hepatitis B virus on development of hepatocellular carcinoma.
    Lyu H; Lee D; Chung YH; Kim JA; Lee JH; Jin YJ; Park W; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ
    J Viral Hepat; 2013 Mar; 20(3):219-24. PubMed ID: 23383661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Susceptibility Mutations in C Gene for Hepatitis B-Related Hepatocellular Carcinoma Identified by a Two-Stage Study in Qidong, China.
    Qu L; Zhang H; Liu J; Liu T; Shen X; Chen T; Ni Z; Lu C
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27727182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity.
    Li MS; Lau TC; Chan SK; Wong CH; Ng PK; Sung JJ; Chan HL; Tsui SK
    PLoS One; 2011; 6(7):e21856. PubMed ID: 21814558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment in selected genotypes, basal core and precore mutations of hepatitis B virus in patients with hepatocellular carcinoma in Cameroon.
    Atsama Amougou M; Marchio A; Bivigou-Mboumba B; Noah Noah D; Banai R; Atangana PJA; Fewou Moundipa P; Pineau P; Njouom R
    J Viral Hepat; 2019 Sep; 26(9):1086-1093. PubMed ID: 31106515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
    J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison study on the complete sequence of hepatitis B virus identifies new mutations in core gene associated with hepatocellular carcinoma.
    Zhu Y; Jin Y; Guo X; Bai X; Chen T; Wang J; Qian G; Groopman JD; Gu J; Li J; Tu H
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2623-30. PubMed ID: 20699378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.
    Tong MJ; Blatt LM; Kao JH; Cheng JT; Corey WG
    Liver Int; 2007 Dec; 27(10):1356-63. PubMed ID: 17900245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors analysis and a new risk scoring system predicting hepatocarcinogenesis for chronic genotype C HBV infected patients].
    Liu JL; Pu R; Ma LT; Wang S; Yin JH; Cao GW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1459-1464. PubMed ID: 30462954
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma.
    Bläckberg J; Kidd-Ljunggren K
    J Med Virol; 2003 Sep; 71(1):18-23. PubMed ID: 12858404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
    Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
    World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan.
    Chen CH; Changchien CS; Lee CM; Tung WC; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
    Int J Cancer; 2009 Aug; 125(3):621-9. PubMed ID: 19431214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of complete sequences of hepatitis B virus genotype C between inactive carriers and hepatocellular carcinoma patients before and after seroconversion.
    Ito K; Tanaka Y; Kato M; Fujiwara K; Sugauchi F; Sakamoto T; Shinkai N; Orito E; Mizokami M
    J Gastroenterol; 2007 Oct; 42(10):837-44. PubMed ID: 17940837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis and hepatocellular carcinoma.
    Zhang KY; Imazeki F; Fukai K; Arai M; Kanda T; Mikata R; Yokosuka O
    Cancer Sci; 2007 Dec; 98(12):1921-9. PubMed ID: 17888035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.